Additionally, COUP-TFII was correlated to clinical stage (significantly higher expressed in stage IV tumors than stage I), histological grade (significantly higher expression with grade) and ERα status (significantly higher expressed in ERα positive than negative breast carcinomas) (117). The gene discussed is NR2F2; the disease is breast carcinoma.